Latest statistics and disclosures from Spring Point Capital's latest quarterly 13F-HR filing:

• Top 5 stock holdings are XRX, DELL, MSFT, SVNT, Abbott Laboratories. These five stock positions account for 35.16% of Spring Point Capital's total stock portfolio.
• Added to shares of Abbott Laboratories (+$16.04M), Bk Of America (+$13.27M), Aeropostale Com Stk (+$10.42M), GOOG (+$7.24M), TRW (+$5.71M), CLW (+$5.61M), LPS (+$5.53M), Platinum Underwriter/ptp, General Mtrs Co *w exp 07/10/201, General Mtrs Co *w exp 07/10/201.
• Started new stock positions in Platinum Underwriter/ptp, GOOG, General Mtrs Co *w exp 07/10/201, Aeropostale Com Stk, General Mtrs Co *w exp 07/10/201, TRW, CLW, Bk Of America, Abbott Laboratories.
• Reduced shares in these stocks: GC (-$24.98M), DGX (-$16.82M), BAC (-$15.57M), (-$15.02M), EP (-$14.54M), ABT (-$14.41M), SYMC (-$14.07M), ARO (-$13.97M), PFE (-$13.02M), MDT (-$12.62M).
• Sold out of its positions in ABT, ARO, AMGN, BAC, BC, CSCO, CSC, CPG, EP, GME, GPS, GC, IACI, KEY, MA, PFE, BPOP, SWY, SNV, Willis Group Holdings.
• As of June 30, 2011, Spring Point Capital has $270.96M in assets under management (AUM). Assets under management dropped from a total value of $482.27M to $270.96M.
• Independent of market fluctuations, Spring Point Capital was a net seller by $194.06M worth of stocks in the most recent quarter.